Human CD34− Hematopoietic Stem Cells: Basic Features and Clinical Relevance
- 96 Downloads
CD34 has been widely used as a stem and progenitor cell marker, and clinical CD34+ stem cell transplantation (CD34+ SCT) has been performed for tumor purging and for prevention of graft-versus-host disease. Recently, CD34-negative hemato-poietic stem cells (CD34− HSCs) were identified in mice and humans. Xenogeneic chimera engraftment assays with immun-odeficient mice or preimmune fetal sheep resulted in identification of human CD34− HSCs in cord blood, bone marrow, and granulocyte colony-stimulating factor-mobilized peripheral blood, although no significant clonogenic activity was detected in vitro. These characteristics of CD34− HSCs make the assessment of clinical samples difficult. The generation of CD34+ HSCs from CD34− cells in vitro may be a surrogate assay for detecting CD34− HSC activity. This approach was used in recipients of CD34+ SCT and revealed the absence of a CD34− precursor population.The identification of a positive marker in CD34− HSCs and the development of a simpler and more efficient in vivo assay for CD34− HSCs may allow the diagnostic evaluation of human CD34− HSCs in various clinical procedures and diseases.
Key wordsCD34 Hematopoietic stem cell Xenogeneic transplantation assay
Unable to display preview. Download preview PDF.
- 17.Nakamura Y, Ando K, Chargui J, et al.Ex vivogeneration of CD34 positive cells from CD34 negative hematopoietic cellsBlood. 1999; 94:4053–4059.Google Scholar
- 22.Zanjani ED, Almeida-Porada G, Livingston AG, Zeng HO, Ogawa M. Long-term engrafting capabilities of CD34-negative human adult marrow cells [abstract].Blood. 1998;92:504a.Google Scholar
- 26.Danet GH, Luongo J, Butler G, Tenner AJ, Bonnet DA. C1qRp: new positive marker for human Lin−CD34−CD38− repopulating cells [abstract].Blood. 2000;96:492a.Google Scholar
- 27.Dooley DC, Oppenlander BK, Plunkett JM. Lin−CD34−CD38− cells from mobilized human peripheral blood: proliferation in serum-free and stroma-based culture systems [abstract].Blood. 1999;94: 465a.Google Scholar
- 36.Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation.Nature. 1999;401:390–394.Google Scholar
- 45.Jahagirdar B, Jiang Y, Reyes M, et al. Multipotent cells derived from adult mouse marrow engraft in a non-injured recipient and differentiate into hematopoietic, epithelial and endothelial tissues [abstract].Blood. 2001;98:547a.Google Scholar